<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Patient Health Record</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">THIEN T TRUONG</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">August 7, 1955 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Asian</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Not Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Vietnamese (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>9605 W POST RD<br/>LAS VEGAS, NV 89148-4720, US<br/><br/>Primary Home Phone:  626-274-6284<br/>Mobile Phone:  626-274-6284<br/>Email:  THIENTTRUONG55@GMAIL.COM<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">31344 2.16.840.1.113883.4.391.317470<br/>31344 2.16.840.1.113883.4.391.317470.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">6225d4ae-3687-4168-a4ea-4c632f55e789 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">February 20, 2025, 10:43:46, PST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">JULIE WU MD</td></tr><tr><td class="td_header_role_value internal_format">3750 S JONES BLVD<br/>STE 120<br/>LAS VEGAS, NV 89103-2209, US<br/><br/>Tel:  702-434-8880<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">THU PHAM</td></tr><tr><td class="td_header_role_value internal_format">5597 SPRING MOUNTAIN RD<br/>LAS VEGAS, NV 89146-8865, US<br/><br/>Tel:  702-434-8880<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">VANNA TRUONG<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">THIEN TRUONG<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  626-274-6284<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">Julie Wu, Inc</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">3750 S JONES BLVD<br/>STE 120<br/>LAS VEGAS, NV 89103-2209, US<br/><br/>Tel:  702-434-8880<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medical (General) History</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL</span><br/>Reviewed date:10/02/2024 02:00:48 PM<br/>Interpretation:<br/>Performing Lab:QAW, Quest Diagnostics-Las Vegas - 4230 Burnham
4230 Burnham Ave, Las Vegas
NV
89119-5408 Christine Ruemmler-Gamble<br/>Notes/Report:<br/>0; 0; 0<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result1_attr1">GLUCOSE</td><td>97</td><td>65-99 mg/dL</td><td ID="result1_attr1_notes"><p/><p>           Fasting reference interval</p></td></tr><tr><td ID="result1_attr2">UREA NITROGEN (BUN)</td><td>16</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result1_attr3">CREATININE</td><td>0.93</td><td>0.70-1.35 mg/dL</td><td/></tr><tr><td ID="result1_attr4">EGFR</td><td>89</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result1_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result1_attr5_notes"><p>   Not Reported: BUN and Creatinine are within</p><p>   reference range.</p></td></tr><tr><td ID="result1_attr6">SODIUM</td><td>138</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result1_attr7">POTASSIUM</td><td>4.4</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result1_attr8">CHLORIDE</td><td>103</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result1_attr9">CARBON DIOXIDE</td><td>25</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result1_attr10">CALCIUM</td><td>9.5</td><td>8.6-10.3 mg/dL</td><td/></tr><tr><td ID="result1_attr11">PROTEIN, TOTAL</td><td>7.2</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result1_attr12">ALBUMIN</td><td>4.7</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result1_attr13">GLOBULIN</td><td>2.5</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result1_attr14">ALBUMIN/GLOBULIN RATIO</td><td>1.9</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result1_attr15">BILIRUBIN, TOTAL</td><td>0.7</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result1_attr16">ALKALINE PHOSPHATASE</td><td>61</td><td>35-144 U/L</td><td/></tr><tr><td ID="result1_attr17">AST</td><td>31</td><td>10-35 U/L</td><td/></tr><tr><td ID="result1_attr18">ALT</td><td>34</td><td>9-46 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">HEMOGLOBIN A1c</span><br/>Reviewed date:10/02/2024 02:00:48 PM<br/>Interpretation:<br/>Performing Lab:QAW, Quest Diagnostics-Las Vegas - 4230 Burnham
4230 Burnham Ave, Las Vegas
NV
89119-5408 Christine Ruemmler-Gamble<br/>Notes/Report:<br/>0; 0; 0<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result2_attr1">HEMOGLOBIN A1c</td><td>5.9</td><td>&lt;5.7 % of total Hgb</td><td ID="result2_attr1_notes"><p>For someone without known diabetes, a hemoglobin</p><p>A1c value between 5.7% and 6.4% is consistent with</p><p>prediabetes and should be confirmed with a</p><p>follow-up test.</p><p>For someone with known diabetes, a value &lt;7%</p><p>indicates that their diabetes is well controlled. A1c</p><p>targets should be individualized based on duration of</p><p>diabetes, age, comorbid conditions, and other</p><p>considerations.</p><p>This assay result is consistent with an increased risk</p><p>of diabetes.</p><p>Currently, no consensus exists regarding use of</p><p>hemoglobin A1c for diagnosis of diabetes for children.</p></td></tr><tr><td colspan="4"><span class="content_span">LIPID PANEL, STANDARD</span><br/>Reviewed date:10/02/2024 02:00:48 PM<br/>Interpretation:<br/>Performing Lab:QAW, Quest Diagnostics-Las Vegas - 4230 Burnham
4230 Burnham Ave, Las Vegas
NV
89119-5408 Christine Ruemmler-Gamble<br/>Notes/Report:<br/>0; 0; 0<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result3_attr1">CHOLESTEROL, TOTAL</td><td>150</td><td>&lt;200 mg/dL</td><td/></tr><tr><td ID="result3_attr2">HDL CHOLESTEROL</td><td>61</td><td>&gt; OR = 40 mg/dL</td><td/></tr><tr><td ID="result3_attr3">TRIGLYCERIDES</td><td>132</td><td>&lt;150 mg/dL</td><td/></tr><tr><td ID="result3_attr4">LDL-CHOLESTEROL</td><td>67</td><td/><td ID="result3_attr4_notes"><p>Reference range: &lt;100</p><p>Desirable range &lt;100 mg/dL for primary prevention;</p><p>&lt;70 mg/dL for patients with CHD or diabetic patients</p><p>with &gt; or = 2 CHD risk factors.</p><p>LDL-C is now calculated using the Martin-Hopkins</p><p>calculation, which is a validated novel method providing</p><p>better accuracy than the Friedewald equation in the</p><p>estimation of LDL-C.</p><p>Martin SS et al. JAMA. 2013;310(19): 2061-2068</p><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p></td></tr><tr><td ID="result3_attr5">CHOL/HDLC RATIO</td><td>2.5</td><td>&lt;5.0 (calc)</td><td/></tr><tr><td ID="result3_attr6">NON HDL CHOLESTEROL</td><td>89</td><td>&lt;130 mg/dL (calc)</td><td ID="result3_attr6_notes"><p>For patients with diabetes plus 1 major ASCVD risk</p><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>option.</p></td></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL</span><br/>Reviewed date:05/10/2024 01:38:48 PM<br/>Interpretation:<br/>Performing Lab:QAW, Quest Diagnostics-Las Vegas - 4230 Burnham
4230 Burnham Ave, Las Vegas
NV
89119-5408 Christine Ruemmler-Gamble<br/>Notes/Report:<br/>0; 0; 0; 0; 0; 0<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result4_attr1">GLUCOSE</td><td>97</td><td>65-99 mg/dL</td><td ID="result4_attr1_notes"><p/><p>           Fasting reference interval</p></td></tr><tr><td ID="result4_attr2">UREA NITROGEN (BUN)</td><td>17</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result4_attr3">CREATININE</td><td>0.85</td><td>0.70-1.35 mg/dL</td><td/></tr><tr><td ID="result4_attr4">EGFR</td><td>95</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result4_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result4_attr5_notes"><p>   Not Reported: BUN and Creatinine are within</p><p>   reference range.</p></td></tr><tr><td ID="result4_attr6">SODIUM</td><td>138</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result4_attr7">POTASSIUM</td><td>4.5</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result4_attr8">CHLORIDE</td><td>102</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result4_attr9">CARBON DIOXIDE</td><td>28</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result4_attr10">CALCIUM</td><td>9.8</td><td>8.6-10.3 mg/dL</td><td/></tr><tr><td ID="result4_attr11">PROTEIN, TOTAL</td><td>7.7</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result4_attr12">ALBUMIN</td><td>4.7</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result4_attr13">GLOBULIN</td><td>3.0</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result4_attr14">ALBUMIN/GLOBULIN RATIO</td><td>1.6</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result4_attr15">BILIRUBIN, TOTAL</td><td>0.4</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result4_attr16">ALKALINE PHOSPHATASE</td><td>69</td><td>35-144 U/L</td><td/></tr><tr><td ID="result4_attr17">AST</td><td>29</td><td>10-35 U/L</td><td/></tr><tr><td ID="result4_attr18">ALT</td><td>37</td><td>9-46 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">CBC (INCLUDES DIFF/PLT)</span><br/>Reviewed date:05/10/2024 01:39:13 PM<br/>Interpretation:<br/>Performing Lab:QAW, Quest Diagnostics-Las Vegas - 4230 Burnham
4230 Burnham Ave, Las Vegas
NV
89119-5408 Christine Ruemmler-Gamble<br/>Notes/Report:<br/>0; 0; 0; 0; 0; 0<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result5_attr1">WHITE BLOOD CELL COUNT</td><td>8.0</td><td>3.8-10.8 Thousand/uL</td><td/></tr><tr><td ID="result5_attr2">RED BLOOD CELL COUNT</td><td>5.13</td><td>4.20-5.80 Million/uL</td><td/></tr><tr><td ID="result5_attr3">HEMOGLOBIN</td><td>16.0</td><td>13.2-17.1 g/dL</td><td/></tr><tr><td ID="result5_attr4">HEMATOCRIT</td><td>48.0</td><td>38.5-50.0 %</td><td/></tr><tr><td ID="result5_attr5">MCV</td><td>93.6</td><td>80.0-100.0 fL</td><td/></tr><tr><td ID="result5_attr6">MCH</td><td>31.2</td><td>27.0-33.0 pg</td><td/></tr><tr><td ID="result5_attr7">MCHC</td><td>33.3</td><td>32.0-36.0 g/dL</td><td/></tr><tr><td ID="result5_attr8">RDW</td><td>13.5</td><td>11.0-15.0 %</td><td/></tr><tr><td ID="result5_attr9">PLATELET COUNT</td><td>261</td><td>140-400 Thousand/uL</td><td/></tr><tr><td ID="result5_attr10">MPV</td><td>10.0</td><td>7.5-12.5 fL</td><td/></tr><tr><td ID="result5_attr11">ABSOLUTE NEUTROPHILS</td><td>4944</td><td>1500-7800 cells/uL</td><td/></tr><tr><td ID="result5_attr12">ABSOLUTE LYMPHOCYTES</td><td>2160</td><td>850-3900 cells/uL</td><td/></tr><tr><td ID="result5_attr13">ABSOLUTE MONOCYTES</td><td>560</td><td>200-950 cells/uL</td><td/></tr><tr><td ID="result5_attr14">ABSOLUTE EOSINOPHILS</td><td>264</td><td>15-500 cells/uL</td><td/></tr><tr><td ID="result5_attr15">ABSOLUTE BASOPHILS</td><td>72</td><td>0-200 cells/uL</td><td/></tr><tr><td ID="result5_attr16">NEUTROPHILS</td><td>61.8</td><td/><td/></tr><tr><td ID="result5_attr17">LYMPHOCYTES</td><td>27.0</td><td/><td/></tr><tr><td ID="result5_attr18">MONOCYTES</td><td>7.0</td><td/><td/></tr><tr><td ID="result5_attr19">EOSINOPHILS</td><td>3.3</td><td/><td/></tr><tr><td ID="result5_attr20">BASOPHILS</td><td>0.9</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">HEMOGLOBIN A1c</span><br/>Reviewed date:05/10/2024 01:38:54 PM<br/>Interpretation:<br/>Performing Lab:QAW, Quest Diagnostics-Las Vegas - 4230 Burnham
4230 Burnham Ave, Las Vegas
NV
89119-5408 Christine Ruemmler-Gamble<br/>Notes/Report:<br/>0; 0; 0; 0; 0; 0<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result6_attr1">HEMOGLOBIN A1c</td><td>6.0</td><td>&lt;5.7 % of total Hgb</td><td ID="result6_attr1_notes"><p>For someone without known diabetes, a hemoglobin</p><p>A1c value between 5.7% and 6.4% is consistent with</p><p>prediabetes and should be confirmed with a</p><p>follow-up test.</p><p>For someone with known diabetes, a value &lt;7%</p><p>indicates that their diabetes is well controlled. A1c</p><p>targets should be individualized based on duration of</p><p>diabetes, age, comorbid conditions, and other</p><p>considerations.</p><p>This assay result is consistent with an increased risk</p><p>of diabetes.</p><p>Currently, no consensus exists regarding use of</p><p>hemoglobin A1c for diagnosis of diabetes for children.</p><p>This test was performed on the Roche cobas c503 platform.</p><p>Effective 11/6/23, a change in test platforms from the</p><p>Abbott Architect to the Roche cobas c503 may have shifted</p><p>HbA1c results compared to historical results.</p><p>Based on laboratory validation testing conducted at</p><p>Quest, the Roche platform relative to the Abbott</p><p>platform had an average increase in HbA1c value of</p><p>&lt; or = 0.3%. This difference is within accepted</p><p>variability established by the National Glycohemoglobin</p><p>Standardization Program. Note that not all individuals</p><p>will have had a shift in their results and direct</p><p>comparisons between historical and current results for</p><p>testing conducted on different platforms is not</p><p>recommended.</p></td></tr><tr><td colspan="4"><span class="content_span">TSH W/REFLEX TO FT4</span><br/>Reviewed date:05/10/2024 01:39:24 PM<br/>Interpretation:<br/>Performing Lab:QAW, Quest Diagnostics-Las Vegas - 4230 Burnham
4230 Burnham Ave, Las Vegas
NV
89119-5408 Christine Ruemmler-Gamble<br/>Notes/Report:<br/>0; 0; 0; 0; 0; 0<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result7_attr1">TSH W/REFLEX TO FT4</td><td>0.60</td><td>0.40-4.50 mIU/L</td><td/></tr><tr><td colspan="4"><span class="content_span">PSA (FREE AND TOTAL)</span><br/>Reviewed date:05/10/2024 01:38:42 PM<br/>Interpretation:<br/>Performing Lab:QAW, Quest Diagnostics-Las Vegas - 4230 Burnham
4230 Burnham Ave, Las Vegas
NV
89119-5408 Christine Ruemmler-Gamble<br/>Notes/Report:<br/>0; 0; 0; 0; 0; 0<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result8_attr1">PSA, TOTAL</td><td>0.9</td><td>&lt; OR = 4.0 ng/mL</td><td/></tr><tr><td ID="result8_attr2">PSA, FREE</td><td>0.3</td><td/><td/></tr><tr><td ID="result8_attr3">PSA, % FREE</td><td>33</td><td>&gt;25 % (calc)</td><td ID="result8_attr3_notes"><p/><p>PSA(ng/mL)      Free PSA(%)     Estimated(x) Probability</p><p>                                     of Cancer(as%)</p><p>0-2.5              (*)               Approx. 1</p><p>2.6-4.0(1)         0-27(2)                   24(3)</p><p>4.1-10(4)          0-10                      56</p><p>                   11-15                     28</p><p>                   16-20                     20</p><p>                   21-25                     16</p><p>                   &gt;or =26                   8</p><p>&gt;10(+)             N/A                      &gt;50</p><p>References:(1)Catalona et al.:Urology 60: 469-474 (2002)</p><p>           (2)Catalona et al.:J.Urol 168: 922-925 (2002)</p><p>              Free PSA(%)   Sensitivity(%)  Specificity(%)</p><p>              &lt; or = 25          85              19</p><p>              &lt; or = 30          93               9</p><p>           (3)Catalona et al.:JAMA 277: 1452-1455 (1997)</p><p>           (4)Catalona et al.:JAMA 279: 1542-1547 (1998)</p><p>(x)These estimates vary with age, ethnicity, family</p><p>   history and DRE results.</p><p>(*)The diagnostic usefulness of % Free PSA has not been</p><p>   established in patients with total PSA below 2.6 ng/mL</p><p>(+)In men with PSA above 10 ng/mL, prostate cancer risk is</p><p>   determined by total PSA alone.</p><p>The Total PSA value from this assay system is</p><p>standardized against the equimolar PSA standard.</p><p>The test result will be approximately 20% higher</p><p>when compared to the WHO-standardized Total PSA</p><p>(Siemens assay). Comparison of serial PSA results</p><p>should be interpreted with this fact in mind.</p><p>PSA was performed using the Beckman Coulter</p><p>Immunoassay method. Values obtained from different</p><p>assay methods cannot be used interchangeably. PSA</p><p>levels, regardless of value, should not be interpreted</p><p>as absolute evidence of the presence or absence of</p><p>disease.</p></td></tr><tr><td colspan="4"><span class="content_span">URINALYSIS, COMPLETE W/REFLEX TO CULTURE</span><br/>Reviewed date:05/10/2024 01:39:05 PM<br/>Interpretation:<br/>Performing Lab:QAW, Quest Diagnostics-Las Vegas - 4230 Burnham
4230 Burnham Ave, Las Vegas
NV
89119-5408 Christine Ruemmler-Gamble<br/>Notes/Report:<br/>0; 0; 0; 0; 0; 0<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result9_attr1">COLOR</td><td>YELLOW</td><td>YELLOW</td><td/></tr><tr><td ID="result9_attr2">APPEARANCE</td><td>CLEAR</td><td>CLEAR</td><td/></tr><tr><td ID="result9_attr3">SPECIFIC GRAVITY</td><td>1.015</td><td>1.001-1.035</td><td/></tr><tr><td ID="result9_attr4">PH</td><td>5.5</td><td>5.0-8.0</td><td/></tr><tr><td ID="result9_attr5">GLUCOSE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result9_attr6">BILIRUBIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result9_attr7">KETONES</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result9_attr8">OCCULT BLOOD</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result9_attr9">PROTEIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result9_attr10">NITRITE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result9_attr11">LEUKOCYTE ESTERASE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result9_attr12">WBC</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td/></tr><tr><td ID="result9_attr13">RBC</td><td>NONE SEEN</td><td>&lt; OR = 2 /HPF</td><td/></tr><tr><td ID="result9_attr14">SQUAMOUS EPITHELIAL CELLS</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td/></tr><tr><td ID="result9_attr15">BACTERIA</td><td>NONE SEEN</td><td>NONE SEEN /HPF</td><td/></tr><tr><td ID="result9_attr16">HYALINE CAST</td><td>NONE SEEN</td><td>NONE SEEN /LPF</td><td/></tr><tr><td ID="result9_attr17">NOTE</td><td/><td/><td ID="result9_attr17_notes"><p>This urine was analyzed for the presence of WBC,</p><p>RBC, bacteria, casts, and other formed elements.</p><p>Only those elements seen were reported.</p></td></tr><tr><td ID="result9_attr18">REFLEXIVE URINE CULTURE</td><td/><td/><td ID="result9_attr18_notes">NO CULTURE INDICATED</td></tr><tr><td colspan="4"><span class="content_span">LIPID PANEL, STANDARD</span><br/>Reviewed date:05/10/2024 01:38:36 PM<br/>Interpretation:<br/>Performing Lab:QAW, Quest Diagnostics-Las Vegas - 4230 Burnham
4230 Burnham Ave, Las Vegas
NV
89119-5408 Christine Ruemmler-Gamble<br/>Notes/Report:<br/>0; 0; 0; 0; 0; 0<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result10_attr1">CHOLESTEROL, TOTAL</td><td>150</td><td>&lt;200 mg/dL</td><td/></tr><tr><td ID="result10_attr2">HDL CHOLESTEROL</td><td>50</td><td>&gt; OR = 40 mg/dL</td><td/></tr><tr><td ID="result10_attr3">TRIGLYCERIDES</td><td>169</td><td>&lt;150 mg/dL</td><td/></tr><tr><td ID="result10_attr4">LDL-CHOLESTEROL</td><td>73</td><td/><td ID="result10_attr4_notes"><p>Reference range: &lt;100</p><p>Desirable range &lt;100 mg/dL for primary prevention;</p><p>&lt;70 mg/dL for patients with CHD or diabetic patients</p><p>with &gt; or = 2 CHD risk factors.</p><p>LDL-C is now calculated using the Martin-Hopkins</p><p>calculation, which is a validated novel method providing</p><p>better accuracy than the Friedewald equation in the</p><p>estimation of LDL-C.</p><p>Martin SS et al. JAMA. 2013;310(19): 2061-2068</p><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p></td></tr><tr><td ID="result10_attr5">CHOL/HDLC RATIO</td><td>3.0</td><td>&lt;5.0 (calc)</td><td/></tr><tr><td ID="result10_attr6">NON HDL CHOLESTEROL</td><td>100</td><td>&lt;130 mg/dL (calc)</td><td ID="result10_attr6_notes"><p>For patients with diabetes plus 1 major ASCVD risk</p><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>option.</p></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>MEADOWS EYE: EYE EXAM | EVAL AND CONSULT </td></tr><tr><th>Diagnosis 1</th><td>Encounter for screening for eye and ear disorders (Z13.5)</td></tr><tr><th>Referral Organization</th><td>HHC - Spring Mountain</td></tr><tr><th>Referring Provider First Name</th><td>THU</td></tr><tr><th>Referring Provider Last Name</th><td>PHAM</td></tr><tr><th>Referring Provider Speciality</th><td>Nurse Practitioner</td></tr><tr><th>Referred Provider Specialty</th><td>Ophthalmology</td></tr><tr><th>General Notes</th><td>Tampon, Joan 05/03/2024 02:53:42 PM &gt;FAXED. TEXTED PT TO INFORM</td></tr><tr><th>Clinical Notes</th><td>Meadows Eye Physicians and Surgeons - Southwest Las Vegas, 5556 S Ft Apache Rd Las Vegas, NV 89148, PH: 702-358-0472, FX: 702-425-9955</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Atorvastatin Calcium 20 MG</td><td ID="instruction1">1 tablet Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Fluticasone Propionate 50 MCG/ACT</td><td ID="instruction2">SPRAY 1 SPRAY INTO EACH NOSTRIL ONCE A DAY for 30</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Atenolol 50 MG</td><td ID="instruction3">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div>No Information</div><h3><a name="id6" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Tobacco Use/Smoking</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Are you a</td><td>nonsmoker</td><td/></tr></tbody></table><span class="content_span">Alcohol Screen (Audit-C)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>Yes</td><td/></tr><tr><td>How often did you have a drink containing alcohol in the past year?</td><td>4 or more times a week (4 points)</td><td/></tr><tr><td>How many drinks did you have on a typical day when you were drinking in the past year?</td><td>3 or 4 drinks (1 point)</td><td/></tr><tr><td>Points</td><td>5</td><td/></tr><tr><td>Interpretation</td><td>Positive</td><td/></tr></tbody></table><span class="content_span">Section Notes:</span><table width="100%" border="1"><tbody><tr><td colspan="3"><p>Caffeine: 1 cup daily </p><p>Exercise: Walking daily</p></td></tr><tr><td colspan="3"><p>Caffeine: 1 cup daily </p><p>Exercise: Walking daily</p></td></tr></tbody></table></div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Alcohol dependence (66590003)</td><td ID="Problem1">Alcohol dependence, uncomplicated (F10.20)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Essential hypertension (59621000)</td><td ID="Problem2">Essential hypertension (I10)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Hyperlipidaemia (55822004)</td><td ID="Problem3">Hyperlipidemia, unspecified hyperlipidemia type (E78.5)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Allergic rhinitis (61582004)</td><td ID="Problem4">Allergic rhinitis, unspecified seasonality, unspecified trigger (J30.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Peripheral vascular disease (400047006)</td><td ID="Problem5">PVD (peripheral vascular disease) (I73.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>51 /min</td><td>10/01/2024</td><td/></tr><tr><th ID="vital2">Temperature</th><td>97.1 degrees Fahrenheit</td><td>10/01/2024</td><td/></tr><tr><th ID="vital3">Oximetry</th><td>98 %</td><td>10/01/2024</td><td/></tr><tr><th ID="vital4">Blood pressure diastolic</th><td>78 mm Hg</td><td>10/01/2024</td><td/></tr><tr><th ID="vital5">Height-cm</th><td>170.18 cm</td><td>10/01/2024</td><td/></tr><tr><th ID="vital6">Weight-kg</th><td>57.97 kg</td><td>10/01/2024</td><td/></tr><tr><th ID="vital7">Height</th><td>5'7" in</td><td>10/01/2024</td><td/></tr><tr><th ID="vital8">Blood pressure systolic</th><td>130 mm Hg</td><td>10/01/2024</td><td/></tr><tr><th ID="vital9">Weight</th><td>127.8 lbs</td><td>10/01/2024</td><td/></tr><tr><th ID="vital10">BMI</th><td>20.01 kg/m2</td><td>10/01/2024</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><span class="content_span">No Information</span></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>Julie Wu, Inc</td><td>3750 S JONES BLVD STE 120 LAS VEGAS, NV 89103-2209</td><td>10/01/2024</td><td>THU PHAM</td><td/></tr><tr><td>Julie Wu, Inc</td><td>3750 S JONES BLVD STE 120 LAS VEGAS, NV 89103-2209</td><td>02/20/2025</td><td>THU PHAM</td><td/></tr><tr><td>Julie Wu, Inc</td><td>3750 S JONES BLVD STE 120 LAS VEGAS, NV 89103-2209</td><td>05/03/2024</td><td>THU PHAM</td><td>Encounter for general adult medical examination with abnormal findings Z00.01 ; Essential hypertension I10 ; Hyperlipidemia, unspecified hyperlipidemia type E78.5 ; Alcohol dependence, uncomplicated F10.20 ; Allergic rhinitis, unspecified seasonality, unspecified trigger J30.9 ; Prediabetes R73.03 ; Encounter for screening for eye and ear disorders Z13.5 ; Depression screen Z13.31 and Former smoker Z87.891</td></tr><tr><td>HHC - Spring Mountain</td><td>5597 SPRING MOUNTAIN RD LAS VEGAS, NV 89146-8865</td><td>10/01/2024</td><td>THU PHAM</td><td>Essential hypertension I10 ; Hyperlipidemia, unspecified hyperlipidemia type E78.5 ; Prediabetes R73.03 ; PVD (peripheral vascular disease) I73.9 and Encounter for general adult medical examination with abnormal findings Z00.01</td></tr><tr><td>Julie Wu, Inc</td><td>3750 S JONES BLVD STE 120 LAS VEGAS, NV 89103-2209</td><td>04/16/2024</td><td>JULIE WU MD</td><td/></tr><tr><td>HHC - Spring Mountain</td><td>5597 SPRING MOUNTAIN RD LAS VEGAS, NV 89146-8865</td><td>06/27/2024</td><td>JULIE WU MD</td><td/></tr><tr><td>Julie Wu, Inc</td><td>3750 S JONES BLVD STE 120 LAS VEGAS, NV 89103-2209</td><td>09/20/2024</td><td>JULIE WU MD</td><td/></tr><tr><td>Julie Wu, Inc</td><td>3750 S JONES BLVD STE 120 LAS VEGAS, NV 89103-2209</td><td>10/02/2024</td><td>JULIE WU MD</td><td>Essential hypertension I10 and Hyperlipidemia, unspecified hyperlipidemia type E78.5</td></tr><tr><td>HHC - Spring Mountain</td><td>5597 SPRING MOUNTAIN RD LAS VEGAS, NV 89146-8865</td><td>02/03/2025</td><td>THU PHAM</td><td>Hyperlipidemia, unspecified hyperlipidemia type E78.5 ; Prediabetes R73.03 ; Encounter for general adult medical examination with abnormal findings Z00.01 ; Essential hypertension I10 and Encounter for screening for malignant neoplasm of prostate Z12.5</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">05/03/2024</td><td>Encounter for general adult medical examination with abnormal findings (ICD-10 - Z00.01)</td><td/><td/><td/><td/></tr><tr><td ID="ref2">05/03/2024</td><td>Essential hypertension (ICD-10 - I10)</td><td/><td><p>Keep bp &lt;140/90</p><p>Monitor bp at home</p><p>Low sodium diet is recommended</p><p>continue bp med(s)</p></td><td/><td/></tr><tr><td ID="ref3">10/01/2024</td><td>Essential hypertension (ICD-10 - I10)</td><td/><td><p>Keep bp &lt;140/90</p><p>Monitor bp at home</p><p>Low sodium diet is recommended</p><p>continue bp med(s)</p></td><td/><td/></tr><tr><td ID="ref4">10/01/2024</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td/><td><p>Recommended to do a low fat diet</p><p>Avoid processed foods, include vegetables and fruits </p><p>continue cholesterol med regimen </p><p>exercises regularly if possible </p></td><td/><td/></tr><tr><td ID="ref5">10/02/2024</td><td>Essential hypertension (ICD-10 - I10)</td><td/><td/><td/><td/></tr><tr><td ID="ref6">02/03/2025</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td/><td/><td/><td/></tr><tr><td ID="ref7">02/03/2025</td><td>Prediabetes (ICD-10 - R73.03)</td><td/><td/><td/><td/></tr><tr><td ID="ref8">10/02/2024</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td/><td/><td/><td/></tr><tr><td ID="ref9">02/03/2025</td><td>Encounter for general adult medical examination with abnormal findings (ICD-10 - Z00.01)</td><td/><td/><td/><td/></tr><tr><td ID="ref10">10/01/2024</td><td>Prediabetes (ICD-10 - R73.03)</td><td/><td><p>low carb diet </p><p>increase exercise</p></td><td/><td/></tr><tr><td ID="ref11">05/03/2024</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td/><td><p>Recommended to do a low fat diet</p><p>Avoid processed foods, include vegetables and fruits </p><p>continue cholesterol med regimen </p><p>exercises regularly if possible </p></td><td/><td/></tr><tr><td ID="ref12">05/03/2024</td><td>Alcohol dependence, uncomplicated (ICD-10 - F10.20)</td><td/><td>advised patient to reduce alcohol/beer intake</td><td/><td/></tr><tr><td ID="ref13">10/01/2024</td><td>PVD (peripheral vascular disease) (ICD-10 - I73.9)</td><td/><td><p>low chol level</p><p>keep bp in good control</p><p>avoid smoking</p><p>aspirin statin as indicated</p><p>daily foot care and monitor ulcer prevention</p><p>exercise to promote vascular health</p></td><td/><td/></tr><tr><td ID="ref14">02/03/2025</td><td>Essential hypertension (ICD-10 - I10)</td><td/><td/><td/><td/></tr><tr><td ID="ref15">10/01/2024</td><td>Encounter for general adult medical examination with abnormal findings (ICD-10 - Z00.01)</td><td/><td/><td/><td/></tr><tr><td ID="ref16">05/03/2024</td><td>Allergic rhinitis, unspecified seasonality, unspecified trigger (ICD-10 - J30.9)</td><td/><td>medications prescribed, explained how to use and medications side effects</td><td/><td/></tr><tr><td ID="ref17">05/03/2024</td><td>Prediabetes (ICD-10 - R73.03)</td><td/><td><p>low carb diet </p><p>increase exercise</p></td><td/><td/></tr><tr><td ID="ref18">02/03/2025</td><td>Encounter for screening for malignant neoplasm of prostate (ICD-10 - Z12.5)</td><td/><td/><td/><td/></tr><tr><td ID="ref19">05/03/2024</td><td>Encounter for screening for eye and ear disorders (ICD-10 - Z13.5)</td><td/><td>REFERRAL FOR OPTHALMOLOGIST FOR EYE CHECK UP</td><td/><td/></tr><tr><td ID="ref20">05/03/2024</td><td>Depression screen (ICD-10 - Z13.31)</td><td/><td><p>Depression Score is 0, Screening for depression is</p><p>documerfied as negatiye and a follow Up plan is not required,</p></td><td/><td/></tr><tr><td ID="ref21">05/03/2024</td><td>Former smoker (ICD-10 - Z87.891)</td><td/><td><p>REFERRAL FOR ROUTINE CHEST XRAY </p><p>pt stopped smoking for 10 years. </p></td><td/><td/></tr><tr><td ID="ref22">05/03/2024</td><td>Other</td><td/><td/><td/><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">LIPID PANEL, STANDARD</td><td>10/02/2024</td></tr><tr><td ID="pendingTest2">CBC (H/H, RBC, INDICES, WBC, PLT)</td><td>02/03/2025</td></tr><tr><td ID="pendingTest3">PSA (FREE AND TOTAL)</td><td>02/03/2025</td></tr><tr><td ID="pendingTest4">HEMOGLOBIN A1c</td><td>10/02/2024</td></tr><tr><td ID="pendingTest5">TSH</td><td>02/03/2025</td></tr><tr><td ID="pendingTest6">COMPREHENSIVE METABOLIC PANEL</td><td>02/03/2025</td></tr><tr><td ID="pendingTest7">Chest; 2 Views X-ray</td><td>05/03/2024</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:THU PHAM, 02/25/2025 08:30:00 AM, 5597 SPRING MOUNTAIN RD, LAS VEGAS, NV, 89146-8865, 702-434-8880</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>AETNA MEDICARE HMO</td><td>PO BOX 14079 LEXINGTON, KY 40512-4000</td><td>888-632-3862</td><td>101205329200</td><td/><td>TRUONG, THIEN</td><td>Self - patient is the insured</td><td>01/01/2022</td><td/></tr><tr><td>Medicaid of Nevada HP</td><td>PO BOX 30042 RENO, NV 89520-3000</td><td>877-638-3472</td><td>00002639488</td><td/><td>TRUONG, THIEN</td><td>Self - patient is the insured</td><td/><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Medical History</span><table width="100%" border="1"><thead><tr><th>History</th><th>ICD Code</th></tr></thead><tbody><tr><td>LABS: 2023, 5/2024</td><td/></tr><tr><td>EYE EXAM: 2023-Corrective</td><td/></tr><tr><td>PROSTATE EXAM: 2024, normal</td><td/></tr><tr><td>COLON CANCER SCREENING: 2022-Colonoscopy-Normal, repeat 2027</td><td/></tr><tr><td>HTN</td><td/></tr><tr><td>High cholesterol</td><td/></tr></tbody></table></div><br/><br/></body></html>